• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

ATG7 多态性与透明细胞肾细胞癌风险的关联。

Association of ATG7 Polymorphisms and Clear Cell Renal Cell Carcinoma Risk.

机构信息

Department of Urology, The Second Affiliated Hospital of Xi'an Jiaotong University, Xi'an, Shaanxi 710004, China.

Department of anesthesiology, Tangdu Hospital of Air Force Military Medical University, Xi'an, Shaanxi 710038, China.

出版信息

Curr Mol Med. 2019;19(1):40-47. doi: 10.2174/1566524019666190227202003.

DOI:10.2174/1566524019666190227202003
PMID:30827239
Abstract

BACKGROUND

Kidney cancer is one of the most common cancers worldwide. Recent studies have suggested that single nucleotide polymorphisms (SNPs) in autophagy-related gene are associated with the risk of kidney cancer.

OBJECTIVE

This study was undertaken to investigate the association of autophagyrelated gene 7 (ATG7) polymorphisms with the risk of clear cell renal cell carcinoma (ccRCC) in the Chinese Han population.

METHODS

Blood samples were collected from 293 ccRCC patients and 297 healthy controls. Three ATG7 polymorphisms (rs1375206, rs2606736 and rs6442260) were genotyped by Agena MassARRAY. The association was estimated by genetic models and stratification analyses.

RESULTS

A significant association was observed between allele A of rs6442260 and ccRCC risk (OR = 0.76, 95% CI: 0.58-0.99, p = 0.039). Genetic model analysis revealed that rs2606736 (OR = 0.57, 95% CI: 0.34-0.95, p = 0.031) and rs6442260 (OR = 0.44, 95% CI: 0.22-0.90, p = 0.021) were associated with decreased risk of ccRCC under recessive model. Age stratification analysis showed that rs2606736 (OR = 0.67, 95% CI: 0.46-0.98, p = 0.036) and rs6442260 (OR = 0.26, 95% CI: 0.07-0.89, p = 0.014) were significantly decreased risk of ccRCC under the log-additive model in age > 55 years old and ≤ 55 years old, respectively.

CONCLUSIONS

This study indicated that ATG7 polymorphisms (rs2606736 and rs6442260) have a protective role for ccRCC risk. Further large sample size and functional assays are needed to confirm our findings and reveal the role of ATG7 polymorphisms in ccRCC carcinogenesis.

摘要

背景

肾癌是全球最常见的癌症之一。最近的研究表明,自噬相关基因中的单核苷酸多态性(SNPs)与肾癌的风险相关。

目的

本研究旨在探讨自噬相关基因 7(ATG7)多态性与中国汉族人群透明细胞肾细胞癌(ccRCC)风险的关系。

方法

收集 293 例 ccRCC 患者和 297 例健康对照者的血样。采用 Agena MassARRAY 法检测 ATG7 基因的 3 个多态性位点(rs1375206、rs2606736 和 rs6442260)。采用遗传模型和分层分析估计相关性。

结果

等位基因 A 的 rs6442260 与 ccRCC 风险显著相关(OR=0.76,95%CI:0.58-0.99,p=0.039)。遗传模型分析显示,rs2606736(OR=0.57,95%CI:0.34-0.95,p=0.031)和 rs6442260(OR=0.44,95%CI:0.22-0.90,p=0.021)在隐性模型下与 ccRCC 风险降低相关。年龄分层分析显示,rs2606736(OR=0.67,95%CI:0.46-0.98,p=0.036)和 rs6442260(OR=0.26,95%CI:0.07-0.89,p=0.014)在年龄>55 岁和≤55 岁的个体中,分别在对数加性模型下与 ccRCC 风险降低显著相关。

结论

本研究表明,ATG7 多态性(rs2606736 和 rs6442260)对 ccRCC 风险具有保护作用。需要进一步进行大样本量和功能检测来验证我们的发现,并揭示 ATG7 多态性在 ccRCC 发生中的作用。

相似文献

1
Association of ATG7 Polymorphisms and Clear Cell Renal Cell Carcinoma Risk.ATG7 多态性与透明细胞肾细胞癌风险的关联。
Curr Mol Med. 2019;19(1):40-47. doi: 10.2174/1566524019666190227202003.
2
XRCC3 Thr241Met and XPD Lys751Gln gene polymorphisms and risk of clear cell renal cell carcinoma.XRCC3基因Thr241Met多态性与XPD基因Lys751Gln多态性及透明细胞肾细胞癌风险
Cancer Biomark. 2016;16(2):211-7. doi: 10.3233/CBM-150558.
3
Association between ACYP2 polymorphisms and the risk of renal cell cancer.ACYP2 多态性与肾细胞癌风险的关联。
Mol Genet Genomic Med. 2019 Nov;7(11):e966. doi: 10.1002/mgg3.966. Epub 2019 Sep 5.
4
Methylenetetrahydrofolate reductase (MTHFR) gene C677T, A1298C and G1793A polymorphisms: association with risk for clear cell renal cell carcinoma and tumour behaviour in men.亚甲基四氢叶酸还原酶(MTHFR)基因 C677T、A1298C 和 G1793A 多态性:与男性透明细胞肾细胞癌风险和肿瘤行为的关联。
Clin Oncol (R Coll Radiol). 2012 May;24(4):269-81. doi: 10.1016/j.clon.2011.03.005. Epub 2011 Apr 13.
5
Variants in angiogenesis-related genes and the risk of clear cell renal cell carcinoma.血管生成相关基因的变异与肾透明细胞癌风险
Mutagenesis. 2014 Nov;29(6):419-25. doi: 10.1093/mutage/geu046. Epub 2014 Sep 18.
6
Genetic Variants in Caveolin-1 and RhoA/ROCK1 Are Associated with Clear Cell Renal Cell Carcinoma Risk in a Chinese Population.小窝蛋白-1和RhoA/ROCK1基因变异与中国人群肾透明细胞癌风险相关。
PLoS One. 2015 Jun 12;10(6):e0128771. doi: 10.1371/journal.pone.0128771. eCollection 2015.
7
One-carbon metabolism pathway gene variants and risk of clear cell renal cell carcinoma in a Chinese population.中国人群中一碳代谢途径基因变异与肾透明细胞癌风险
PLoS One. 2013 Nov 21;8(11):e81129. doi: 10.1371/journal.pone.0081129. eCollection 2013.
8
CTLA-4 and CD28 genes' polymorphisms and renal cell carcinoma susceptibility in the Polish population--a prospective study.CTLA-4和CD28基因多态性与波兰人群肾细胞癌易感性的前瞻性研究
Tissue Antigens. 2015 Nov;86(5):353-61. doi: 10.1111/tan.12671. Epub 2015 Sep 25.
9
Combined effects of DNA methyltransferase 1 and 3A polymorphisms and urinary total arsenic levels on the risk for clear cell renal cell carcinoma.DNA甲基转移酶1和3A基因多态性与尿总砷水平对肾透明细胞癌风险的联合影响
Toxicol Appl Pharmacol. 2016 Aug 15;305:103-110. doi: 10.1016/j.taap.2016.06.011. Epub 2016 Jun 9.
10
A novel functional polymorphism of GSTM3 reduces clear cell renal cell carcinoma risk through enhancing its expression by interfering miR-556 binding.一种新型的 GSTM3 功能多态性通过干扰 miR-556 的结合来增强其表达,从而降低透明细胞肾细胞癌的风险。
J Cell Mol Med. 2018 Jun;22(6):3005-3015. doi: 10.1111/jcmm.13528. Epub 2018 Mar 22.

引用本文的文献

1
Therapeutic targeting of P2X4 receptor and mitochondrial metabolism in clear cell renal carcinoma models.靶向治疗 P2X4 受体和线粒体代谢在透明细胞肾细胞癌模型中的应用。
J Exp Clin Cancer Res. 2023 May 26;42(1):134. doi: 10.1186/s13046-023-02713-1.
2
Association of ATG7 gene polymorphisms with microscopic polyangiitis in Chinese individuals.中国人群中ATG7基因多态性与显微镜下多血管炎的关联
Am J Transl Res. 2022 Oct 15;14(10):7239-7251. eCollection 2022.
3
Autophagopathies: from autophagy gene polymorphisms to precision medicine for human diseases.
自噬病理:从自噬基因多态性到人类疾病的精准医学。
Autophagy. 2022 Nov;18(11):2519-2536. doi: 10.1080/15548627.2022.2039994. Epub 2022 Apr 6.
4
Emerging roles of ATG7 in human health and disease.ATG7 在人类健康和疾病中的新兴作用。
EMBO Mol Med. 2021 Dec 7;13(12):e14824. doi: 10.15252/emmm.202114824. Epub 2021 Nov 2.
5
SETD2 mutation in renal clear cell carcinoma suppress autophagy via regulation of ATG12.SETD2 突变通过调控 ATG12 抑制肾透明细胞癌自噬
Cell Death Dis. 2020 Jan 27;11(1):69. doi: 10.1038/s41419-020-2266-x.
6
Differentially expressed autophagy-related genes are potential prognostic and diagnostic biomarkers in clear-cell renal cell carcinoma.差异表达的自噬相关基因是透明细胞肾细胞癌潜在的预后和诊断生物标志物。
Aging (Albany NY). 2019 Oct 17;11(20):9025-9042. doi: 10.18632/aging.102368.